[{"Assets_0_Q2_USD":302926000.0,"CommonStockSharesOutstanding_0_Q2_shares":52375945.0,"EarningsPerShareBasic_1_Q2_USD":0.09,"EarningsPerShareBasic_2_Q2_USD":0.16,"EarningsPerShareDiluted_1_Q2_USD":0.09,"EarningsPerShareDiluted_2_Q2_USD":0.15,"NetIncomeLoss_1_Q2_USD":4611000.0,"NetIncomeLoss_2_Q2_USD":7677000.0,"StockholdersEquity_0_Q2_USD":251271000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":53945640.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":51101464.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52172982.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":49270829.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180802"}]